We are live on ! Find out more
KTOVW

Kitov Pharma Ltd. Warrants
KTOVW

Delisted

KTOVW was delisted on the 23rd of November, 2020.

Back to rankings

5 hedge funds and large institutions have $26K invested in Kitov Pharma Ltd. Warrants in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,200% more capital invested

Capital invested by funds: $2K → $26K (+$24K)

400% more funds holding

Funds holding: 1 → 5 (+4)

Holders
5
Holders Change
+4
Holders Change %
+400%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.74K
2
Citadel Advisors
Citadel Advisors
Florida
+$1.25K
3
HF
HRT Financial
New York
+$1.1K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CAI
1
Capital Advisors Inc
Oklahoma
$7K – – –
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$6K +$1.74K +30,352 New
VF
3
Virtu Financial
New York
$6K +$1.91K +33,352 New
Citadel Advisors
4
Citadel Advisors
Florida
$4K +$1.25K +21,818 New
HF
5
HRT Financial
New York
$3K +$1.1K +19,105 New

KTOVW Hedge Fund Activity: Q2 2020 in Review

5 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Kitov Pharma Ltd. Warrants (KTOVW) for Q2 2020, worth a combined $26K — up 1,200% from $2K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new KTOVW positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.74K.

  • 5 institutional investors held Kitov Pharma Ltd. Warrants (KTOVW) as of Q2 2020, up from 1 in Q1 2020.
  • Funds reported $26K of Kitov Pharma Ltd. Warrants stock for Q2 2020, up 1,200% quarter-over-quarter.
  • 4 funds opened new Kitov Pharma Ltd. Warrants positions in Q2 2020 and 0 closed out, a net change of +4 holders.
  • The largest Kitov Pharma Ltd. Warrants buyer in Q2 2020 was Susquehanna International Group, an estimated $1.74K added.

Based on aggregated 13F filings for Q2 2020.